Fig S1 Relative mRNA expression MCF7 pS2 * * * * * CCNG2 * * * * * * RPRM * * * * KLF6 * * * * * * CLDN4 * * * CERK * * * EFEMP1 * * * ENC1 * * BIK * *

Slides:

Advertisements

Similar presentations

Supplementary Fig. 1. Transcriptome analysis of MENX-associated pituitary adenomas and and comparison with human studies. Control samples from wild-type.

Advertisements

Supplementary Figure 1. DAXX S564A does not change Mdm2/p53 stability or p53 ‑ mediated gene expression. (A) U2OS cells stably transduced with pCDH-DAXX.

Fig. 1 Screening for miRNAs that regulate primordial follicle assembly in mouse ovaries. (a) A flow chart of the screening strategy. miRNAs that expressed.

Fig. 1 (A) (B) (C) * * * * Mock siRNA siRNA Day 3 Day DNA-PKcs Beta actin.

Supplemental Figure 1: ER  expression in MCF-7 cells. MCF-7 cells were either pre-treated with ICI 182,780 (lanes 5-8) or EtOH (vehicle, lanes 1-4) for.

Sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2 IB: p-Ser KD 70KD 60KD 70KD (abnova) sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2.

B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.

Supplemental Table S1 Table S1. Quantitative real-time RT-PCR primer sequences for genes used in the publication. All sequences are listed in the 5’ –

Fig. 1. GLP-1 induces miR-132 and miR-212 expression in pancreatic β-cells in vitro and in vivo. (A) MiRNA expression profiling of GLP-1 treated INS-1.

Supplementary Figure S1 FPKM ESRP1ESRP2 normaltumor Supplementary Figure S1. ESRP1 and ESRP2 mRNA expression in 65 normal kidney samples and 474 ccRCC.

Supplementary Figure 1. Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer. (A-C) CDK7, CyclinH and MAT1 mRNA levels, determined by real-time.

Supplementary Figure S1. Knockdown of Twist1 mRNA increases Foxa1 expression in MDA-MB-436 cells. Total RNA and protein samples were prepared from MDA-MB-436.

Training Set Clinicopathological parameters of the training set

Fig. 1 UGT2B15 mRNA levels are stimulated by E2 in a time- and dose-dependent manner in MCF-7 breast cancer cells. A, Time course for E2 treatment. Cells.

Progesterone receptor

Fig. 1. ER binding assays. (A) Mouse ER

Supplementary Figure 1: Clinical parameters of the breast tumor samples used for the study. IDC = Invasive ductal carcinoma and ILC= Invasive Lobular.

Network protein vulnerability in EGFR TKI‐resistant cells and specific for EGFR‐mutated cells. Network protein vulnerability in EGFR TKI‐resistant cells.

CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.

The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFβ1 A. van Caam, E. Blaney Davidson, A.

A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC

Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7 M.M.J. Caron, P.J.

Volume 49, Issue 3, Pages (February 2013)

Volume 5, Issue 6, Pages (December 2013)

Cytotoxic therapy induces macrophage recruitment, as well as CSF1 and IL-34 mRNA expression. Cytotoxic therapy induces macrophage recruitment, as well.

Volume 22, Issue 12, Pages (December 2015)

ECM 29 and Kaplan–Meier survival curves for additional datasets

17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production Naoko Kanda, Shinichi.

(A) Schematic representation of the conditional Lats1 locus.

Volume 56, Issue 1, Pages (October 2014)

MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

Minchul Kim, Taekhoon Kim, Randy L. Johnson, Dae-Sik Lim Cell Reports

Volume 29, Issue 4, Pages (February 2008)

Volume 10, Issue 6, Pages (December 2006)

MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer

Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate- Cancer-Associated Mutants Jian An, Chenji Wang, Yibin Deng, Long Yu,

Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.

Regulated P124SMEK1 expression cannot alter p-ERK levels or sensitivity to BRAF or MEK inhibition in V600EBRAF melanoma cell lines. Regulated P124SMEK1.

Michael J. McDonald, Michael Rosbash Cell

Qing Feng, Sujatha Jagannathan, Robert K. Bradley Molecular Cell

HOXB7 interacts with ERα and enhances expression of ER target genes.

Molecular Therapy - Nucleic Acids

A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.

Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

R.D. Chavez, G. Coricor, J. Perez, H.-S. Seo, R. Serra

Volume 5, Issue 6, Pages (December 2013)

Volume 14, Issue 3, Pages (March 2014)

Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation. Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation.

Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.

CREB1 promotes the induction of endogenous ERα target genes.

Effect of the siRNA-mediated knockdown of endogenous MARCH8 on the expression levels of MARCH8 substrates, TfR and CD98, in HepG2 cells. Effect of the.

Fig. 2. Acetylation stiffens primary cilia.

Fig. 6. RhoB is required for Rnd3-induced stress fibre formation

Volume 24, Issue 1, Pages (July 2018)

Volume 22, Issue 12, Pages (December 2015)

Figure 4. MicroRNA (miR)-195 and miR-497 directly targets CD274

Sensor siRNAs can be used in high-order combinations.

Depletion of HDAC2 sensitizes cells to epirubicin-induced apoptosis.

TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.

FcRγ signaling regulates BTK activation and mediates PDAC growth.

Pirh2 represses p73-dependent transactivation.

Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.

Fig. 3. KMS99220 inhibits activation of NFκB signaling via HO-1 induction. (A) BV2 cells were treated with 10 µM KMS99220 for 1 h, and then treated with.

VC KX-01 Total Src p-Y416 Src Supplementary Figure S1. KX-01 at low dose inhibited phosphorylation of Src in MDA-MB-231 xenografts.

EGFR signaling regulates transcription of PDGFRβ gene.

Transcriptional activity and growth of mutant ER in a breast cancer cell line. Transcriptional activity and growth of mutant ER in a breast cancer cell.

Decreased dopamine uptake following downregulation of SLC6A3.

Volume 19, Issue 3, Pages (September 2010)

Presentation transcript:

Fig S1 Relative mRNA expression MCF7 pS2 * * * * * CCNG2 * * * * * * RPRM * * * * KLF6 * * * * * * CLDN4 * * * CERK * * * EFEMP1 * * * ENC1 * * BIK * * * * * * HBP1 * * * * * CXCR4 * * * * RAP1GA1 * * * * CDH3 * * BMP7 * * MXD4 * * * * MUC1 * * * * NDRG1 * * * RBL2 * BAKp21PLK2 * DUSP4 * * * 4 hr8 hr24 hr4 hr8 hr24 hr4 hr8 hr24 hr4 hr8 hr24 hr Fig S1: Identification of estrogen-repressed genes in MCF7 cells. q-RT-PCR was used to confirm the estrogen-mediated repression of candidate genes identified from microarray data. The relative mRNA expression is depicted as ligand-mediated fold change compared to vehicle control. MCF7 cells were treated for 4, 8, or 24 hours with either vehicle, estrogen (E2), or a combination of E2 and ICI (E2+ICI). The data are an average of three replicates + SEM. A t-test analysis was performed in which the E2 treatment group was compared to the vehicle group and the E2+ICI group was compared to the E2 group (* p < 0.05).

Fig S2 Fig S2: Estrogen-mediated repression of selected genes in breast cancer cells. q-RT-PCR was used to confirm the estrogen-mediated repression of candidate genes identified from microarray data. The relative mRNA expression is depicted as ligand-mediated fold change compared to vehicle control. (A) ZR-75-1 and (B) T47D cells were treated for 4, 8, or 24 hours with either vehicle, estrogen (E2), or a combination of E2 and ICI. The data are an average of three replicates + SEM. A t-test analysis was performed in which the E2 treatment group was compared to the vehicle group and the E2+ICI group was compared to the E2 group (* p < 0.05). Relative mRNA expression ZR-75-1 CERK 4 hr8 hr24 hr RPRM * * * KLF6 * * CLDN4 * * * EFEMP1 * 4 hr8 hr24 hr ENC1 4 hr8 hr24 hr A B Relative mRNA expression T47D RPRMKLF6 CERKEFEMP1 ENC1 CLDN4 * * * * * * * * * 4 hr8 hr24 hr4 hr8 hr24 hr4 hr8 hr24 hr

Fig S3 Fig S3: Identification of E2-repressed genes that are primary ERα targets. (A) MCF7 cells were treated with either vehicle, estrogen (E2), or a combination of E2 and cycloheximide (CHX). q-RT-PCR was used to calculate relative mRNA expression as ligand- mediated fold change compared to vehicle control. This fold change is reflected in the color intensity as shown in the legend. A 4h8h E2 CHX E2 Fold change < > CLDN4 EFEMP1 CERK KLF6 ENC1 BIK HBP1 CXCR4 RAP1GA1 CDH3 BMP7 MXD4 NDRG1 RBL2 FLOT1 RND3 TENS1 IER3

Fig S4 Fig S4: Knockdown of HDAC1-10 and its effect on RPRM expression. MCF7 cells were transfected with non-specific siRNA (siNS) or siRNA against HDAC1-10 (siHDAC1-10) followed by either a vehicle or an E2 treatment for 12 hrs. The knockdown of each HDAC is shown in (A) and its effect on RPRM expression is shown in (B). q-RT-PCR was used to calculate relative mRNA expression as fold change compared to vehicle control. The data are an average of three replicates + SEM. A HDAC1HDAC2HDAC3HDAC4HDAC5 HDAC6HDAC7HDAC8HDAC9HDAC10 Relative mRNA expression siNSsiHDAC1siNSsiHDAC2siNSsiHDAC3siNSsiHDAC4siNSsiHDAC5 siNSsiHDAC6siNSsiHDAC7siNSsiHDAC8siNSsiHDAC9siNSsiHDAC10 B RPRM Relative mRNA expression siNSsiHDAC1siNSsiHDAC2siNSsiHDAC3siNSsiHDAC4siNSsiHDAC5 siNSsiHDAC6siNSsiHDAC7siNSsiHDAC8siNSsiHDAC9siNSsiHDAC10

Fig S5 Fig S5: Localization and expression of the HDAC7 deletion and mutant constructs. (A) 293 cells were transfected with Flag-HDAC, Flag-HDAC7 (1-487), Flag-HDAC7 ( ), and Flag-HDAC7 (H670A) and immunostained for Flag. (B) 293 cells were transfected with Flag-HDAC, Flag-HDAC7 (1-487), Flag-HDAC7 ( ), and Flag-HDAC7 (H670A) and blot for Flag and β-actin. B HDAC7: HDAC7 (1-487): - HDAC7 ( ): HDAC7 (H670A): β-actin Flag MW (kDa) HDAC7HDAC7(1-487)HDAC7 ( )HDAC7 (H670A) A

* A SYBR Green assay was used for genes lacking a probe. *